Patients highly value routine follow-up of skin cancer and cutaneous melanoma

Research output: Contribution to journalJournal articleResearchpeer-review

INTRODUCTION: Skin cancer follow-up is a substantial burden to outpatient clinics. Few studies have investigated patients' views on skin cancer follow-up and cutaneous melanoma. The objective was to investigate patients' perceived benefits and the impact of follow-up.

MATERIAL AND METHODS: This study included an open sample of patients attending routine follow-up at the outpatient Departments of Plastic Surgery and Dermatology, Roskilde Hospital. A total of 218 follow-up patients diagnosed with cutaneous malignant melanoma (MM), non-melanoma skin cancer (NMSC) or actinic keratosis (AK) completed a structured interview.

RESULTS: A total of 97% patients found follow-up useful. Continuity and consistency were important. One third of patients felt some degree of pre follow-up anxiety. The number of anxious MM patients was significantly greater than that of NMSC patients. No significant difference was found between the number of anxious MM and AK patients. Female gender, cohabitation and age younger than 50 years were associated with increased levels of anxiety. No relation was found between the number of anxious patients or the level of anxiety and the duration of the follow-up period.

CONCLUSION: The majority of patients who attended found that the follow-up had been useful. Certain demographic characteristics were associated with higher levels of anxiety and may be addressed by supportive efforts targeting these groups.

Original languageEnglish
JournalUgeskrift for Laeger
Volume60
Issue number10
Pages (from-to)A4713
ISSN0041-5782
Publication statusPublished - Oct 2013

    Research areas

  • Adult, Aged, Aged, 80 and over, Anxiety, Attitude to Health, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Continuity of Patient Care, Female, Health Care Surveys, Humans, Keratosis, Actinic, Male, Melanoma, Middle Aged, Neoplasm Recurrence, Local, Patient Satisfaction, Prognosis, Secondary Prevention, Skin Neoplasms, Young Adult

ID: 120840501